AlphaCentric Advisors »

Adma Biologics shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $343k 19k 18.24

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Adma Biologics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Sachem Head Capital Management
Westfield Capital Management Company
Capital Research Global Investors
Geode Capital Management
Nuveen
American Century Companies
Dimensional Fund Advisors
UBS Group
Thrivent Financial for Lutherans
Citadel Advisors
Caligan Partners

View all funds holding Adma Biologics